Chancellor Rachel Reeves Intends Focused Action on Living Costs in Forthcoming Budget
Treasury head Rachel Reeves has announced she is planning "specific steps to address cost of living challenges" in the upcoming Budget.
Speaking to the BBC, she noted that reducing inflation is a joint task of both the government and the central bank.
The UK's inflation rate is expected to be the highest among the Group of Seven industrialized countries this calendar year and the following year.
Potential Utility Cost Measures
Reports indicate the government could intervene to reduce energy bills, for instance by slashing the present 5% level of value-added tax charged on energy.
A further option is to reduce some of the regulatory levies presently added to household expenses.
Fiscal Limitations and Expert Predictions
The administration will obtain the next assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for such measures.
The consensus from most analysts is that Reeves will have to introduce tax increases or budget cuts in order to fulfill her self-imposed borrowing rules.
Earlier on Thursday, estimates showed there was a £22bn shortfall for the chancellor to fill, which is at the lower end of expectations.
"It is a collective responsibility between the Bank of England and the administration to further reduce some of the drivers of price increases," the Chancellor informed the BBC in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.
Revenue Pledges and Global Concerns
While much of the attention has been on probable tax rises, the Treasury chief said the most recent figures from the fiscal watchdog had not altered her commitment to manifesto promises not to raise rates on income tax, VAT or National Insurance.
She attributed an "uncertain world" with increasing international and commercial concerns for the Budget tax moves, probably to be directed on those "with the broadest shoulders."
Global Economic Disputes
Referring to concerns about the United Kingdom's commercial links with China she said: "The UK's national security invariably come first."
Last week's declaration by China to increase trade restrictions on critical minerals and other materials that are crucial for advanced tech production led American leader Donald Trump to propose an further 100% tariff on goods from the Asian country, raising the prospect of an all-out trade war between the two largest economies.
The American finance chief labeled China's decision "economic coercion" and "a international production power grab."
Asked about accepting the American proposal to participate in its conflict with the Asian nation, the Chancellor said she was "deeply worried" by Chinese measures and encouraged the Beijing authorities "to avoid restrictions and restrict access."
She said the action was "bad for the international commerce and creates further obstacles."
"In my view there are sectors where we must address Chinese policies, but there are also significant chances to trade with China's economy, including banking sector and other areas of the economy. We've got to achieve that equilibrium right."
The Treasury chief also stated she was cooperating with G7 counterparts "regarding our own essential resources approach, so that we are reduced dependence."
NHS Medicine Pricing and Investment
The Chancellor also recognized that the price the NHS spends on pharmaceuticals could rise as a result of current talks with the Trump administration and its pharmaceutical firms, in exchange for lower tariffs and investment.
A number of the biggest global drug companies have said in recent statements that they are either delaying or scrapping projects in the UK, with several blaming the insufficient payments they are obtaining.
Last month, the Science Minister said the cost the health service spends on drugs would need to go up to prevent businesses and pharmaceutical investment leaving the United Kingdom.
The Chancellor informed media: "We have seen because of the cost structure, that medical research, new drugs have not been offered in the United Kingdom in the extent that they are in other European countries."
"We want to guarantee that individuals receiving care from the NHS are can receive the best life-saving medicines in the globe. And so we are looking at this situation, and... looking to attract additional investment into Britain."